EBIM
CCRN

Eagle Boston Investment Management’s Cross Country Healthcare CCRN Stock Holding History

Eagle Boston Investment Management’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$709K Sell
75,616
-72,504
-49% -$558K 0.81% 64
2019
Q1 		$1.04M Sell
148,120
-77,634
-34% -$665K 0.46% 87
2018
Q4 		$1.65M Sell
225,754
-526,105
-70% -$4.41M 0.57% 76
2018
Q3 		$6.56M Sell
751,859
-13,193
-2% -$135K 0.59% 77
2018
Q2 		$8.61M Buy
765,052
+32,417
+4% +$387K 0.79% 70
2018
Q1 		$8.14M Buy
732,635
+31,517
+4% +$395K 0.81% 62
2017
Q4 		$8.95M Buy
701,118
+40,923
+6% +$541K 0.89% 51
2017
Q3 		$9.56M Buy
660,195
+23,775
+4% +$298K 0.98% 46
2017
Q2 		$8.22M Buy
636,420
+75,650
+13% +$975K 0.89% 55
2017
Q1 		$8.05M Buy
560,770
+29,305
+6% +$431K 0.9% 45
2016
Q4 		$8.3M Buy
531,465
+3,763
+0.7% +$51.5K 0.99% 40
2016
Q3 		$6.22M Buy
527,702
+22,723
+4% +$299K 0.8% 58
2016
Q2 		$7.03M Buy
504,979
+13,540
+3% +$179K 0.95% 43
2016
Q1 		$5.71M Buy
491,439
+26,916
+6% +$342K 0.79% 60
2015
Q4 		$7.61M Sell
464,523
-16,363
-3% -$260K 1.07% 34
2015
Q3 		$6.54M Buy
480,886
+18,548
+4% +$252K 0.88% 50
2015
Q2 		$5.86M Sell
462,338
-118,926
-20% -$1.35M 0.74% 64
2015
Q1 		$6.89M Sell
581,264
-279,129
-32% -$3.2M 0.58% 80
2014
Q4 		$10.7M Sell
860,393
-184,685
-18% -$1.89M 0.71% 65
2014
Q3 		$9.71M Sell
1,045,078
-20,194
-2% -$155K 0.54% 81
2014
Q2 		$6.95M Sell
1,065,272
-41,237
-4% -$273K 0.35% 103
2014
Q1 		$8.93M Sell
1,106,509
-21,439
-2% -$211K 0.44% 93
2013
Q4 		$11.3M Buy
1,127,948
+158,982
+16% +$1.1M 0.54% 75
2013
Q3 		$5.86M Sell
968,966
-19,862
-2% -$114K 0.36% 91
2013
Q2 		$5.1M Buy
+988,828
New +$5.07M 0.34% 95

Other funds holding CCRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BSP
Benefit Street Partners New York $69.6M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Eagle Boston Investment Management's CCRN Position: Q2 2019 in Review

Eagle Boston Investment Management reduced its Cross Country Healthcare (CCRN) stake by 49% in Q2 2019, selling an estimated $558K and leaving 75,616 shares worth $709K. The position accounts for 0.81% of the portfolio, ranked #64.

Eagle Boston Investment Management first reported a position in CCRN in Q2 2013 and has held it in 25 quarters since. The position peaked at $11.3M in Q4 2013. 121 funds tracked by Wall St. Rank hold CCRN as of Q2 2019.

  • Eagle Boston Investment Management held 75,616 shares of Cross Country Healthcare worth $709K as of Q2 2019.
  • Eagle Boston Investment Management sold 72,504 Cross Country Healthcare shares in Q2 2019, an estimated $558K.
  • Cross Country Healthcare made up 0.81% of Eagle Boston Investment Management's portfolio in Q2 2019, its #64 holding.
  • Eagle Boston Investment Management first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 25 quarters since.
  • Eagle Boston Investment Management's Cross Country Healthcare position peaked at $11.3M in Q4 2013.
  • 121 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2019.

Based on Eagle Boston Investment Management's 13F filing for Q2 2019, filed 5 Aug 2019.